10-Q · May 14, 2026
Streamex Corp. reported another quarter of zero revenue, with a dilutive EPS loss of -46.70, reflecting a significant increase in operational expenses primarily due to stock-based compensation. The company continues to…
Earnings analysis · 10-Q
STEX earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q text does not include income-statement, balance-sheet, segment, or cash-flow figures, so revenue, margins, EPS, and free cash flow cannot be assessed. The filing nevertheless presents a bearish risk…
Read full summary
The supplied 10-Q text does not include income-statement, balance-sheet, segment, or cash-flow figures, so revenue, margins, EPS, and free cash flow cannot be assessed. The filing nevertheless presents a bearish risk profile: disclosure controls remained ineffective as of June 30, 2026, with 4 unremediated material weaknesses. Liquidity and operating exposure is heightened by the unsecured transfer of $5.0 million of USDC and 1,069 GLDY tokens to one trading counterparty, alongside dependence on USDC settlement.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Control remediation actions underway
Management hired a corporate controller during the quarter and engaged third-party technical accounting and financial-reporting advisors to address control deficiencies.
-
New stock repurchase authorization
The company authorized a stock repurchase plan for up to 10,000,000 shares at a price not exceeding $2.00 per share; no shares had been repurchased as of the filing.
-
Independent auditor changed
The company changed its independent auditor effective July 8, 2026, replacing CBIZ CPAs P.C. with EisnerAmper LLP; CBIZ’s prior reports for fiscal years 2025 and 2024 were not qualified or modified.
What to watch
-
Unremediated material weaknesses
Disclosure controls remained ineffective as of June 30, 2026 because 4 material weaknesses identified at December 31, 2025 had not been remediated. Management stated there can be no assurance remediation will succeed.
-
Concentration with unsecured counterparty
On July 1, 2026, the company transferred $5.0 million of USDC and 1,069 GLDY tokens to a single independent proprietary trading firm under an unsecured, interest-free loan, representing a substantial majority of digital-asset holdings as of June 30, 2026.
-
USDC depeg and regulatory exposure
Substantially all GLDY secondary-market transactions are settled in USDC, which is not FDIC-insured. The filing cites a March 2023 depegging event involving approximately $3.3 billion of Circle reserves held at Silicon Valley Bank and warns that a future depeg could impair redemptions and market liquidity.
Management's outlook
The extracted 10-Q text does not provide quantitative revenue or EPS guidance. Outlook was not provided in the supplied filing text.
Earlier filings 4
10-K · March 31, 2026
Streamex (formerly BioSig) completed a strategic pivot into tokenized real-world assets by acquiring Streamex Exchange (May 28, 2025), rebranding to STEX (Sept 12, 2025), and launching a gold-backed token (GLDY) on Feb…
10-Q · August 15, 2025
BioSig reported zero revenue for the quarter ended June 30, 2025 and a materially wider net loss of $20.4 million (Q2 2025) versus $3.9 million (Q2 2024). The period reflects a transformational acquisition (Streamex)…
10-Q · May 19, 2025
BioSig Technologies, Inc. reported a net loss of $2.8 million for Q1 2025, an improvement from a $3.4 million loss in Q1 2024, as revenue dropped to zero from $14, indicating challenges in generating sales. The company…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.